Agilent Technologies said it closed the underwritten public offering of 4.200% Senior Notes due 2027 totaling $600 million and 4.750% Senior Notes due 2034 totaling $600 million on September 9, 2024.

1. 01

   Agilent Technologies said it closed the underwritten public offering of 4.200% Senior Notes due 2027 totaling $600 million and 4.750% Senior Notes due 2034 totaling $600 million on September 9, 2024.

2. 02

   The company said it issued the 2027 Notes at 99.866% of principal amount and the 2034 Notes at 99.638%. The notes mature on September 9, 2027 and September 9, 2034, respectively, and bear interest at a rate of 2 times a year, payable semi-annually in arrears, beginning on March 9, 2025.

3. 03

   The company said that if the BioVectra Acquisition is not completed by the Special Mandatory Redemption End Date, or if the company notifies the trustee that it will not pursue the acquisition, it must redeem all of the 2027 Notes at 101% of the aggregate principal amount. It said the 2034 Notes are not subject to this mandatory redemption provision.

4. 04

   The company said it may redeem the 2027 Notes before the Par Call Date at a price equal to the greater of a make-whole amount based on the Treasury Rate plus 10 basis points and a par amount, and the 2034 Notes at a price based on the Treasury Rate plus 20 basis points, among other terms. It also said it must offer to repurchase the notes at 101% of principal amount upon a Change of Control Repurchase Event.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.